David H. Kerman
University of Miami(US)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Gut microbiota and health, Immunodeficiency and Autoimmune Disorders, Clostridium difficile and Clostridium perfringens research
Most-Cited Works
- → Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis(2020)285 cited
- → Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry(2020)199 cited
- → Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD(2020)174 cited
- → CORRELATION OF ELISA-DETECTED IgG AND IgA ANTI-HLA ANTIBODIES IN PRETRANSPLANT SERA WITH RENAL ALLOGRAFT REJECTION1(1996)80 cited
- → Gut Microbiota and Inflammatory Bowel Disease: The Role of Antibiotics in Disease Management(2014)53 cited
- → Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients(2019)37 cited
- → Predictive factors for clinically actionable computed tomography findings in inflammatory bowel disease patients seen in the emergency department with acute gastrointestinal symptoms(2013)34 cited
- → Anti-HLA antibodies detected in posttransplant renal allograft recipient sera correlate with chronic rejection(1997)33 cited
- → Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBD(2022)32 cited
- Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.(1998)